» 모두 » 주식 예측 » Summit Therapeutics Inc. Common Stock 예측

Summit Therapeutics Inc. Common Stock 예측: 내일, 주, 월, 5년

업데이트됨: April 22 · 2026 at 07:03 UTC
▲ +5.02%Market Cap $20.47B · Technical analysis Bullish · Focus area Price + volatility

예측 요약

기간예상 가격과거역사적인통찰력
내일$26.80 +1.59%어제$26.20 -0.67%Tomorrow's Summit Therapeutics Inc. Common Stock (SMMT) setup is anchored to $26.38 and targets $26.80 (+1.59%). The near-term read is upside; watch $27.17 / $25.59 because daily realized volatility is about 8.00%.
Tomorrow's Summit Therapeutics Inc. Common Stock (SMMT) setup is anchored to $26.38 and targets $26.80 (+1.59%). The near-term read is upside; watch $27.17 / $25.59 because daily realized volatility is about 8.00%.
$27.69 +4.95%지난주$25.83 -2.08%The 7-day Summit Therapeutics Inc. Common Stock model moves from $25.83 to $27.69 (+4.95%). It gives upside momentum context for this stock, so breaks around $27.17 / $25.59 matter more than a single tick.
The 7-day Summit Therapeutics Inc. Common Stock model moves from $25.83 to $27.69 (+4.95%). It gives upside momentum context for this stock, so breaks around $27.17 / $25.59 matter more than a single tick.
$29.16 +10.54%전달$25.21 -4.43%The 1-month Summit Therapeutics Inc. Common Stock target is $29.16 (+10.54%), compared with the live reference near $26.38. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Summit Therapeutics Inc. Common Stock target is $29.16 (+10.54%), compared with the live reference near $26.38. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
년도$31.37 +18.93%작년$24.28 -7.95%The 1-year Summit Therapeutics Inc. Common Stock scenario points to $31.37 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Summit Therapeutics Inc. Common Stock scenario points to $31.37 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5년$36.56 +38.57%5년 전$22.11 -16.20%The 5-year Summit Therapeutics Inc. Common Stock view is $36.56 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Summit Therapeutics Inc. Common Stock view is $36.56 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
내일$26.80 +1.59%
어제$26.20 -0.67%
Tomorrow's Summit Therapeutics Inc. Common Stock (SMMT) setup is anchored to $26.38 and targets $26.80 (+1.59%). The near-term read is upside; watch $27.17 / $25.59 because daily realized volatility is about 8.00%.
$27.69 +4.95%
지난주$25.83 -2.08%
The 7-day Summit Therapeutics Inc. Common Stock model moves from $25.83 to $27.69 (+4.95%). It gives upside momentum context for this stock, so breaks around $27.17 / $25.59 matter more than a single tick.
$29.16 +10.54%
전달$25.21 -4.43%
The 1-month Summit Therapeutics Inc. Common Stock target is $29.16 (+10.54%), compared with the live reference near $26.38. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
년도$31.37 +18.93%
작년$24.28 -7.95%
The 1-year Summit Therapeutics Inc. Common Stock scenario points to $31.37 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5년$36.56 +38.57%
5년 전$22.11 -16.20%
The 5-year Summit Therapeutics Inc. Common Stock view is $36.56 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

가격 차트

역사적인예측강세약세
$28.25$27.48$26.71$25.94$25.171W AgoNow7D F

기술적 분석

팔다중립적구입하다
Bullish
2
강세
3
중립적
0
약세

주요 지표

지시자신호
Price$26.38 Mid
Daily Change+5.02% Above
Volatility Cap20.0% Mid
Confidence68% Above
Data Sourcenasdaq-screener Mid

과거 데이터

Current$26.38
Daily Change+5.02%
Market Cap$20.47B
Sourcenasdaq-screener
Current$26.38Daily Change+5.02%
Market Cap$20.47BSourcenasdaq-screener

지지 및 저항 수준

$25.59Support 1
$26.38현재의
$27.17Resistance 1
shield
Support and resistance are estimated from the trusted current price until deeper historical data is available.

가격 이정표

주요 수준 및 역사적 맥락
Current$26.38Live reference price
Used as the anchor for generated forecast calculations.
Next Month$29.16Model projection+10.54%
Directional scenario based on capped drift.

예측 정확도

우리 모델의 성능
68%
방향성
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
우리의 알고리즘은 최신 가격 조치, 변동성 체제 및 지표 신호를 사용하여 매주 재보정됩니다. 정확도는 기간에 따라 다릅니다. 단기적인 모멘텀이 장기 예측보다 더 안정적입니다.
Short term
68%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

투자 시나리오

오늘 SMMT에 $1,000를 투자한다면
Bullish Scenario
$27.70
+5.00% from current
목표가격$27.70
대본Upside momentum
개연성60%
Base Scenario
$29.16
+10.54%
목표가격$29.16
대본Capped drift
개연성68%
Bearish Scenario
$25.06
-5.00% from current
목표가격$25.06
대본Volatility drawdown
개연성32%
기초: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

예측 요인

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bullish · 72/100
24H drift+1.59%
7D drift+4.95%
30D drift+10.54%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-On Tentative · 69/100
1M outlook+10.54%
1Y outlook+18.93%
5Y outlook+38.57%

자주 묻는 질문

Q What is the Summit Therapeutics Inc. Common Stock (SMMT) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Summit Therapeutics Inc. Common Stock is projected near $26.80 versus the current reference around $26.38. That implies a modeled move of +1.59% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for SMMT?
The weekly Summit Therapeutics Inc. Common Stock model points to $27.69, which maps to an expected drift of +4.95% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the Summit Therapeutics Inc. Common Stock 1-month and 1-year targets?
The Summit Therapeutics Inc. Common Stock 1-month target is $29.16 (+10.54%), while the 1-year target is $31.37 (+18.93%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the Summit Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?
The Summit Therapeutics Inc. Common Stock long-horizon scenario sits near $36.56 with a modeled change of +38.57%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are SMMT support and resistance zones right now?
For Summit Therapeutics Inc. Common Stock, nearest resistance is around $25.59, while nearest support is around $27.17. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the Summit Therapeutics Inc. Common Stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.